Document is current
Any future updates will be listed below
-
Authors
Willems, Laurent M.
Strzelczyk, Adam
Rosenow, Felix
Zöllner, Johann Philipp
- License Information
-
More Information
Article History
Accepted: 5 June 2023
First Online: 25 July 2023
Declarations
:
: A. Strzelczyk received consultancy fees, speaker’s fees, and/or research support from Angelini (Arvelle) Pharma, Desitin Arzneimittel, Eisai, Jazz (GW) Pharmaceuticals, Marinus Pharmaceuticals, Precisis, Takeda, UCB (Zogenix) Pharma, and UNEEG Medical. F. Rosenow discloses honoraria from Arvelle Therapeutics, Eisai GmbH, GW Pharmaceuticals Companies, and UCB Medical. He also receives research funding from DFG, BMBF, EU and the Hessian Ministries for Science and the Arts and for Social Affairs and Integration. J.P. Zöllner declares speaker’s fees from Desitin, Eisai, and GW Pharmaceuticals. L.M. Willems declares that he has no competing interests.
: No studies on humans or animals were performed by the authors for this article. For the studies listed, the ethical guidelines stated there apply in each case.
: The supplement containing this article is not sponsored by industry.
Free to read: This content has been made available to all.
